文献速递慢性肾脏病遗传性与小管间质肾病

糖尿病与COVID-19相关肾病中的SARS-CoV-2受体网络

SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.
PubMed 文献 · Kidney Int · 2020-10-08

该研究利用单细胞RNA测序分析健康供者和糖尿病肾病患者的肾活检组织,发现ACE2主要表达于近端小管上皮细胞,且糖尿病肾病中ACE2表达水平不受RAAS抑制剂影响。贝叶斯整合分析识别出ACE2阳性近端小管细胞中诱导的分子网络模块,与病毒 entry、免疫激活等相关,并在COVID-19患者尿液中观察到类似表达程序。

要点

  • ACE2在肾脏主要定位于近端小管上皮细胞,糖尿病肾病中其表达不受RAAS抑制剂影响。
  • 糖尿病肾病ACE2阳性近端小管细胞模块与SARS-CoV-2感染细胞的表达模式重叠。
  • COVID-19患者尿液ACE2阳性近端小管细胞显示一致的ACE2共调控表达程序。

核心结论

  • SARS-CoV-2受体网络在糖尿病肾病和COVID-19相关肾损伤中可能通过近端小管上皮细胞的分子程序发挥作用。

研究设计与样本

  • 单细胞RNA测序分析健康供者和糖尿病肾病患者的肾活检组织,并用原位杂交确认。
  • 对大型公共组学数据集进行贝叶斯整合分析。
  • 分析13例住院COVID-19患者尿液样本中的ACE2阳性近端小管上皮细胞。

主要发现

  • ACE2表达主要位于近端小管上皮细胞,糖尿病肾病中ACE2表达水平不受RAAS抑制剂影响。
  • 贝叶斯整合分析识别出糖尿病肾病ACE2阳性近端小管细胞中诱导的分子网络模块,与病毒entry、免疫激活、内膜重组和RNA加工相关。
  • 糖尿病肾病ACE2阳性近端小管细胞模块与SARS-CoV-2感染细胞的表达模式重叠。
  • COVID-19患者尿液ACE2阳性近端小管细胞显示类似的细胞程序。

临床怎么用

  • 提示糖尿病肾病患者近端小管上皮细胞的ACE2相关分子网络可能影响SARS-CoV-2感染风险,为风险分层和治疗策略提供研究方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

COVID-19 morbidity and mortality are increased via unknown mechanisms in patients with diabetes and kidney disease. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) for entry into host cells. Because ACE2 is a susceptibility factor for infection, we investigated how diabetic kidney disease and medications alter ACE2 receptor expression in kidneys. Single cell RNA profiling of kidney biopsies from healthy living donors and patients with diabetic kidney disease revealed ACE2 expression primarily in proximal tubular epithelial cells. This cell-specific localization was confirmed by in situ hybridization. ACE2 expression levels were unaltered by exposures to renin-angiotensin-aldosterone system inhibitors in diabetic kidney disease. Bayesian integrative analysis of a large compendium of public -omics datasets identified molecular network modules induced in ACE2-expressing proximal tubular epithelial cells in diabetic kidney disease (searchable at hb.flatironinstitute.org/covid-kidney) that were linked to viral entry, immune activation, endomembrane reorganization, and RNA processing. The diabetic kidney disease ACE2-positive proximal tubular epithelial cell module overlapped with expression patterns seen in SARS-CoV-2-infected cells. Similar cellular programs were seen in ACE2-positive proximal tubular epithelial cells obtained from urine samples of 13 hospitalized patients with COVID-19, suggesting a consistent ACE2-coregulated proximal tubular epithelial cell expression program that may interact with the SARS-CoV-2 infection processes. Thus SARS-CoV-2 receptor networks can seed further research into risk stratification and therapeutic strategies for COVID-19-related kidney damage.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Menon R, Otto EA, Sealfon R, et al. SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease. Kidney Int. 2020. PMID: 33038424. doi:10.1016/j.kint.2020.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。